Target intelligence / Profile preview

Dehydrogenase enzyme

Molecular classification
Enzyme, Oxidoreductase
01

Overview

A **dehydrogenase enzyme** is a member of the oxidoreductase family (EC class 1), catalyzing the removal of hydrogen atoms from substrates in oxidation-reduction reactions[1][3][6][8]. Typically, dehydrogenases use coenzymes such as NAD+, NADP+, FAD, or FMN as electron acceptors, facilitating essential steps in major metabolic pathways including glycolysis, the citric acid cycle, fatty acid oxidation, and amino acid catabolism[1][3][4][8]. The term "dehydrogenase enzyme" is generic and refers to a large group of distinct enzymes (such as alcohol dehydrogenase, lactate dehydrogenase, pyruvate dehydrogenase, aldehyde dehydrogenase, etc.), each with specific substrates and biological roles[3][7][1]. Dysregulation or mutation of individual dehydrogenases is associated with diseases including certain cancers, metabolic disorders, cardiovascular and neurological diseases[1][2]. Certain dehydrogenases can serve as biomarkers (e.g., elevated serum LDH as a marker of tissue damage or tumor activity, ALDH activity for some cancer stem cells)[1][2]. Many drugs act by targeting specific dehydrogenases (e.g., disulfiram inhibits aldehyde dehydrogenase for alcohol aversion therapy; metformin inhibits mitochondrial glycerol-3-phosphate dehydrogenase for diabetes management; brequinar targets dihydroorotate dehydrogenase in cancer)[1][8]. Because "dehydrogenase enzyme" is a non-specific, collective term rather than a single defined molecular target, information may need to be refined to a specific isoform or family member for actionable therapeutic or research use[3].

Other names
DehydrogenaseOxidoreductase (when appropriate)e.g. "Alcohol dehydrogenase,""Lactate dehydrogenase," etc.
02

Mechanism of action

Enzyme inhibition, Enzyme activation, Modulation of metabolic flux

03

Biological functions

Oxidation-reduction (redox) reactionsCellular metabolismEnergy productionRedox balance
04

Disease associations

CancerCardiovascular diseaseNeurological diseaseAlcohol intoleranceOther (depends on specific dehydrogenase type)
05

Safety considerations

Off-target metabolic disruptionAccumulation of toxic substrates (e.g. aldehydes)Drug interactions due to metabolic pathway overlap
06

Interacting drugs

Ethanol

4 more in the full profile.

07

Biomarkers

ALDH activity (for cancer stem cells)Serum lactate dehydrogenase (LDH; in oncology and tissue damage)Others (depends on enzyme variant)

Beyond the preview

Go deeper on Dehydrogenase enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dehydrogenase enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call